glp 1 and liver cirrhosis Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty disease? Pioglitazone with SGLT2 inhibitors or

In a first-of-its-kind U.S

The booming class of GLP-1 drugs that includes Ozempic and Wegovy is also showing early potential to help with Parkinsons disease, a new study suggests.

The responsible message: Substantial weight loss usually includes some loss of lean tissue

But does it balance cost and safety, or just look good on the surface

Demand for GLP-1 medications is booming, but healthy, sustained weight loss takes more than just medication

As access to compounded GLP-1 injections recently became increasingly restricted, many patients turned to the gray market an underground network where medications are sold outs